Targeting protein kinases for the development of anti-inflammatory drugs
Author:
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 21 (2) , 317-324
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signalingNature Immunology, 2008
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIKNature Immunology, 2008
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient miceBiochemical Journal, 2008
- Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: A MLK-3-MKK7-dependent mechanismCellular Signalling, 2008
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein KinaseJournal of Biological Chemistry, 2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunityJournal of Experimental Medicine, 2007
- Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1Journal of Experimental Medicine, 2006
- Tumor Necrosis Factor-induced Toxic Liver Injury Results from JNK2-dependent Activation of Caspase-8 and the Mitochondrial Death PathwayJournal of Biological Chemistry, 2006